Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bioengineering
Sirtris Pharmaceuticals Reports Second Quarter 2007 Financial Results; Significant Progress Toward 2007 Goals
August 31st, 2007
Sirtris Pharmaceuticals, Inc. (NASDAQ: SIRT), a biopharmaceutical company focused on discovering and developing small molecule drugs to treat diseases of aging, announced that it reported its consolidated financial results for the quarter ended June 30, 2007 and also commented on certain other recent corporate accomplishments. "We have made important advances in sirtuin drug discovery this year, and anticipate further progress," said Christoph Westphal, M.D., Ph.D., Chief Executive Officer of Sirtris Pharmaceuticals, Inc. "In particular, we have continued to advance our development pipeline. Our initial clinical candidate, SRT501, is in two Phase 1b studies in patients...
Source: Drug Week (2007-08-31)
|
